![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Martek Biosciences Corp. (MM) | NASDAQ:MATK | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 31.49 | 0 | 01:00:00 |
By Kate Gibson, MarketWatch
NEW YORK (MarketWatch) -- U.S. stocks began higher on Tuesday with sentiment bolstered by a round of corporate deals, including Toronto-Dominion Bank's $6.3 billion acquisition of Chrysler Financial.
The Dow Jones Industrial Average (DJI) climbed 31.41 points, or 0.3%, to 11,509.54, with 25 of its 30 components on the rise.
The Dow "has made three attempts to close above 11,500 over the last 10 days and failed each time. That level appears to be a troublesome technical price resistance points that could prove stubborn to penetrate this week," noted Fred Dickson, chief investment strategist at Davidson Companies.
Rising for a fourth consecutive session, the Standard & Poor's 500 Index (SPX) rose 4.53 points, or 0.4%, to 1,251.61. The financial sector proved the best performer among the index's 10 industry groups, while consumer staples lagged.
The Nasdaq Composite (RIXF) gained 9.9 points, or 0.4%, to 2,659.52.
For every issue falling about two advanced on the New York Stock Exchange, where volume approached 127 million at 10 a.m. Eastern.
Adobe Systems Inc. (ADBE) gained after the graphic software maker forecast a profit that beat expectations. Jabil Circuit Inc. (JBL) also climbed after its outlook exceeded Wall Street projections.
In addition to Toronto-Dominion Bank's (TD) agreement to acquire the lending arm of auto manufacturer Chrysler, Dutch chemicals company Royal DSM NV said it plans to purchase biotechnology firm Martek Biosciences Corp. (MATK) for $1.09 billion.
1 Year Martek Chart |
1 Month Martek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions